An international team of leading researchers and clinicians here provide a comprehensive, epidemiological overview of this multi-faceted and still perplexing disorder, and address some of the key questions it raises. How important in the genetic contribution to schizophrenia? Do pregnancy and birth complications increase the risk for schizophrenia? Is the incidence of schizophrenia changing? Why is the rate higher among immigrants and in those born in cities? Controversial issues such as the validity of discrete or dimensional classifications of schizophrenia and the continuum between psychosis and 'normality' are explored in depth, and separate chapters are devoted to topics of particular relevance to schizophrenia such as suicide, violence and substance abuse. Finally, new prospects for treatment and prevention are considered. Drawing together the findings from social, genetic, developmental and classical epidemiology of schizophrenia, this text will prove an invaluable resource for clinicians and researchers.

Salinization of soils is a major threat to irrigated agriculture and counteracts the targets of costly public infrastructure investments. In this study, salinization is regarded as the outcome of an institutional arrangement which impedes the effective implementation of well-known and well-established control measures be they technical, managerial or economic. In public irrigation systems neither the management units nor the farmers are offered any incentives towards the control of high groundwater levels and salinization if the management units are embedded in a highly centralized non-market institutional setting. The author answers the question under which conditions management units and irrigators are active in halting and reversing the process of salinization.

Schizophrenia remains an important challenge to psychiatry, with its causes and underlying brain mechanisms yet to be fully revealed. Currently available treatments are neither universally effective nor without unwanted effects. These aspects, together with the high prevalence of schizophrenia, its often debilitating nature, and the associated family and social burden, make this mental disorder one of the most complex public health issues of our times. The purpose of the Advances in Schizophrenia Research series is to provide comprehensive periodic reviews of the wide range of research studies carried out around the world, with the dual purpose of solving the schizophrenia puzzle, and providing clues to new forms of treatment and prevention for this disorder. A special feature of the series is its broad scope, virtually encompassing all fields of schizophrenia research: epidemiology and risk factors; psychopathology; diagnostic boundaries; cognition; outcome and prognosis; pathophysiology; genetics; pharmacological and psychological forms of treatment and rehabilitation; community care; and stigmatization.

By itself or in combination with an affective disorder, early onset schizophrenia (EOS) — the onset of symptoms before 18 years of age — can create severe deficits in young people’s academic performance, family and peer relationships, and even the ability to acquire new skills. The relative rarity of the condition, meanwhile, can leave school personnel unsure of how to meet — or even recognize — student needs. Identifying, Assessing, and Treating Early Onset Schizophrenia at School emphasizes the importance of providing teachers and students alike with the support needed to enhance academic performance and improve social skills of children and adolescents with EOS within educational settings. In addition, its evidence-based framework enables school professionals to achieve greater confidence and accuracy in identifying students with EOS and provide appropriate services, both in special education and general classes. In this authoritative and accessible volume, experts offer the most salient information on early onset schizophrenia, including: Contributing factors and risk factors. Prevalence and epidemiology. Screening and assessment procedures. Guidelines for determining eligibility for special education programs under IDEIA and Section 504. Latest findings on school-based and off-campus interventions for EOS. A useful resource appendix. Identifying, Assessing, and Treating Early Onset Schizophrenia at School gives school psychologists and allied education professionals both a practical understanding of this disabling condition and the most up-to-date strategies for providing earlier and effective interventions.

The new edition of this critically praised textbook continues to provide the most comprehensive overview of the concepts, methods, and research advances in the field; particularly the application of molecular genomics and of neuroimaging. It has been revised and enhanced to capitalize on the strengths of the first and second editions while keeping it up-to-date with the field of psychiatry and epidemiology. This comprehensive publication now includes chapters on experimental epidemiology, gene-environment interactions, the use of case registries, eating disorders, suicide, childhood disorders and immigrant populations, and the epidemiology of a number of childhood disorders. As in the first and second editions, the objective is to provide a comprehensive, easy to understand overview of research methods for the non-specialist. The book is ideal for students of psychiatric epidemiology, psychiatric residents, general psychiatrists, and other mental health professionals. The book features a new editor, Peter Jones, from the University of Cambridge, who joins the successful US team of Ming Tsuang and Mauricio Tohen.

This book comprises the conferences and discussions presented at the 4th sym posium on the SEARCH FOR THE CAUSES OF SCHIZOPHRENIA, which took place in Guaruja, Brazil, November 1998. This series of symposia started in 1986, on the occasion of the 600th anniversary of the University of Heidelberg, followed by two others in 1989 and 1993. From these meeting resulted three volumes that have been widely used as a reference for comprehensive reviews on the state of the art in schizophrenia research. They reflect the progresses result ing from the most relevant studies on the etiology of the disease. The spirit of the 4th "Search for the Causes" remains the same: again we gathered some of the most prominent researchers on schizophrenia to contrib ute not only with their own data, but also summing up the state of the art and the perspectives in their areas of work. The topics covered in 6 parts are Epide miology, Risk factors and antecedents, Genetics, Neuropathology and neuro chemistry, Brain imaging and function, and Treatment and rehabilitation. In this 4th volume were introduced in each topic a chapter on the "Balance of the Cen tury", to summarize what did we learn (and what we did not) in the last 100 years of schizophrenia research. We hope that this volume can help us to see how far we are in the Search for the Causes of Schizophrenia and how much further we still have to go before our problem can be solved.

Schizophrenia is one of the most complex and puzzling diseases toaffect mankind. It is the most common of the severe mentalillnesses (psychoses) with an estimated prevalence of 0.5 - 1% inthe general population and accounts for a very large portion of theday to day workload of the average psychiatrist. 50% of long-termpsychiatric patients in mental hospitals are schizophrenic. There is a great deal of controversy about the causes, diagnosisand treatment of schizophrenia with the consequence that a hugeamount of research is carried out in the field by psychiatrists,psychologists, neuroscientists and pharmacologists. For the averagepractising psychiatrist seeing schizophrenics on a regular basis,making sense of the vast body of information on the subject andfiltering out what is of clinical relevance can be very difficult.There is a constant stream of new drugs emerging and the newergeneration of drugs (the so-called atypicals) is very effective,but often expensive. The Editors (one American and one British) are both highlyrespected clinical psychiatrists who are probably the leadingexperts on schizophrenia from their respective countries andjointly have published almost 150 papers on the subject. They have brought together a strong group of contributors from theUSA, UK and Europe to produce what will be an essential referencefor the trainee and practising psychiatrist. The book consists of four sections; descriptive aspects,causative aspects, physical treatments andpsychological/behavioural/social treatments. There will bediscussion of the theoretical controversies over symptomatology,classification and aetiology, the relationship of schizophrenia tothe other psychoses, the significance of positive and negativesymptoms and pre-morbid personality. There will be chapters onorganic models of schiziophrenia, neurodevelopmental, genetic andstructural studies and the role of high-expressed emotion. Thefinal section will cover social and environmental treatment, therole of the families of schizophrenics and the psychoanalyticaltherapies. There is a new chapter on the patient's perspectivewritten by a former patient.

Epidemiology of Chronic Disease: Global Perspectives is the most current and authoritative resource on the epidemiology, etiology, pathogenesis, risk factors and preventive factors of over 50 major chronic diseases and conditions. This comprehensive text provides readers with an excellent basis for examining current hypotheses regarding chronic disease epidemiology.

Thoroughly updated and completely reorganized for a sharper clinical focus, the Fifth Edition of this world-renowned classic synthesizes the latest advances in basic neurobiology, biological psychiatry, and clinical neuropsychopharmacology. The book establishes a critical bridge connecting new discoveries in molecular and cellular biology, genetics, and neuroimaging with the etiology, diagnosis, and treatment of all neuropsychiatric disorders. Nine sections focus on specific groups of disorders, covering clinical course, genetics, neurobiology, neuroimaging, and current and emerging therapeutics. Four sections cover neurotransmitter and signal transduction, emerging methods in molecular biology and genetics, emerging imaging technologies and their psychiatric applications, and drug discovery and evaluation. Compatibility: BlackBerry(R) OS 4.1 or Higher / iPhone/iPod Touch 2.0 or Higher /Palm OS 3.5 or higher / Palm Pre Classic / Symbian S60, 3rd edition (Nokia) / Windows Mobile(TM) Pocket PC (all versions) / Windows Mobile Smartphone / Windows 98SE/2000/ME/XP/Vista/Tablet PC

The "epigenetic puzzle" which is schizophrenia, forms the focus of this Monograph, But The Authors Do Not Sit Comfortably With The Notion That this is an entity. Rather, they approach the non-affective psychoses on a broad epidemiological base, ascertaining cases of so-called "functional" psychoses over a quarter of a century. They examine admission policies, showing that patients are admitted to hospital on the grounds of their particular presentation, rather than their diagnosis. They explore Differences Between Males And Females With Psychotic Disorders, And Show that gender is a more powerful influence than diagnosis. They investigate trends over time, and find that demography is the major influence. Looking at criminality, they show that the factors predicting criminal Behaviour In Individuals With Psychotic Illness Are Much The Same In those without psychotic illness. And they trace the longitudinal course of illness, putting paid to the schizophrenia/manic depression dichotomy.; This monograph is an overview of the ideas and many of the findings generated by a highly productive group of researchers. It has a good chance to become one of the standard references in several of the key aspects of schizophrenia.